PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 1993Science831 citations

CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome

View Full Paper
RAR.Cutler AllenRARichard J. ArmitageMCMary Ellen Conley

Key Points

  • Investigate whether genetic defects in the CD40 ligand (CD40L) gene cause X-linked hyper-IgM syndrome by disrupting T-cell-dependent B-cell activation.
  • Analyzed CD40L complementary DNAs (cDNAs) isolated from four patients diagnosed with X-linked hyper-IgM syndrome.
  • Recombinantly expressed mutant CD40L cDNAs to evaluate binding to CD40 and stimulation of normal B-cell proliferation and IgE secretion.
  • Assessed CD40L surface expression on activated patient T cells and measured patient B-cell response to wild-type CD40L.
  • Identified distinct point mutations in CD40L cDNAs from three of four patients with hyper-IgM syndrome.
  • Expressed mutant CD40L proteins failed to bind CD40 and were unable to stimulate proliferation or IgE secretion in normal B cells.
  • Activated T cells from all four patients failed to express functional wild-type CD40L, whereas patient B cells responded normally to wild-type CD40L stimulation.

Abstract

The ligand for CD40 (CD40L) is a membrane glycoprotein on activated T cells that induces B cell proliferation and immunoglobulin secretion. Abnormalities in the CD40L gene were associated with an X-linked immunodeficiency in humans hyper-IgM (immunoglobulin M) syndrome. This disease is characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. CD40L complementary DNAs from three of four patients with this syndrome contained distinct point mutations. Recombinant expression of two of the mutant CD40L complementary DNAs resulted in proteins incapable of binding to CD40 and unable to induce proliferation or IgE secretion from normal B cells. Activated T cells from the four affected patients failed to express wild-type CD40L, although their B cells responded normally to wild-type CD40L. Thus, these CD40L defects lead to a T cell abnormality that results in the failure of patient B cells to undergo immunoglobulin class switching.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Allen et al. (1993) studied this question.

synapsesocial.com/papers/6a1b355c7a950b444096801chttps://doi.org/10.1126/science.7679801
Ask AI
Helpful
Bookmark
Share
View Full Paper